Access to Medical Cannabis

Debate between Matt Hancock and Ben Bradshaw

Monday 8th April 2019 Commons Chamber

[Matt Hancock]

If I may, Mr Speaker, I would like to add to my previous answer by congratulating my hon. Friend the Member for Watford, the former Business Minister, on all that he did to support business, enterprise and the case for capitalism while he was in his former job. I regret his departing from the Government, because he was a brilliant Minister.

On the question ahead of me, so to speak, the Chair of the Select Committee, the hon. Member for Totnes (Dr Wollaston), is right to say that it is vital to bring forward these clinical trials, and that the pharmaceutical companies that provide the oils have not pushed forward the trials in the way that would normally happen. We have therefore stepped in to try to make them happen, but we do need the calls to be answered.

[Mr Ben Bradshaw (Exeter) (Lab)]

The Secretary of State talks about removing barriers, but it is clear to me that the main barrier is the British Paediatric Neurology Association itself. When its president came to give evidence to the Health and Social Care Committee a couple of weeks ago, he was arrogant, he was dismissive of the families’ experience, and he misled our Committee by denying that Members of this House had sought a dialogue with him, which he had refused. What is the Secretary of State going to do to remove the obstacle of the BPNA?

[Matt Hancock]

I am sure that the BPNA will have heard that testimony from the right hon. Gentleman. Of course, the BPNA is independent of Government, and we have to follow the clinical judgments made by the relevant organisations, whether a royal college or, as in this case, an association. What I have done is ensure that a second opinion is available, because the BPNA guidance is merely guidance; it is not absolute. A clinician on the specialist register can make a decision according to what they think is best for the patient in front of them.

Oral Answers to Questions

Debate between Matt Hancock and Ben Bradshaw

Tuesday 26th March 2019 Commons Chamber

[Matt Hancock]

I met the parents of some of the children whose needs are best met through the use of medicinal cannabis. My heart goes out to those who are fighting for this cause. We changed the law in the autumn to try to make it easier, and I am looking very closely at what we can do to make sure that the intention of that decision is met.

[Mr Ben Bradshaw (Exeter) (Lab)]

The Health Committee heard last week that patients are dying unnecessarily and up to a million families are being driven to criminality by getting medical cannabis illegally, and the situation has got worse since the Government changed the law in November. When are these families going to get access to medical cannabis for their children and other sufferers that they would have access to if they lived in Germany, the Netherlands, Canada or the United States?

[Matt Hancock]

As the right hon. Gentleman knows, I supported and indeed participated in the decision to ensure that access was made legal in the autumn, and I am working right now on trying to make sure that some of the challenges in the system are unblocked. Ultimately, these things have to be clinician led, but my sympathy is with those who are campaigning, whom I have met, because I know of the anguish that this problem is causing.

Oral Answers to Questions

Debate between Matt Hancock and Ben Bradshaw

Tuesday 27th November 2018 Commons Chamber

[Mr Ben Bradshaw (Exeter) (Lab)]

T8. To mark the 30th World AIDS Day on Saturday, will the Government commit to a more ambitious, but completely achievable, target of ending all new HIV infections by 2030?

[Matt Hancock]

I join the right hon. Gentleman in celebrating World Aids Day and ensuring that we redouble our commitment to making sure that we do everything we can. I will certainly look into the precise commitment that he asks for to make sure not only that it is deliverable but that we work not just here but around the world to end this scourge.

Oral Answers to Questions

Debate between Matt Hancock and Ben Bradshaw

Tuesday 23rd October 2018 Commons Chamber

[Mr Ben Bradshaw (Exeter) (Lab)]

Is it true that the Secretary of State is now so worried about the supply of vital medicines in the event of a no deal or a hard Brexit that he has asked the pharmaceutical industry to extend the period of stockpiling from six weeks to 20 weeks?

[Matt Hancock]

No, that is not true. We are working very closely with the pharmaceutical industry to make sure that, in the event of a no-deal Brexit, which I regard as unlikely, we mitigate as much as possible the impact on the supply of medicines and that the supply of medicines can be unhindered.

Cambridge Analytica: Data Privacy

Debate between Matt Hancock and Ben Bradshaw

Monday 19th March 2018 Commons Chamber

[Matt Hancock]

There is no evidence yet of successful interference in a UK election or referendum, but we remain vigilant.

[Mr Ben Bradshaw (Exeter) (Lab)]

Given the important role that Cambridge Analytica played in the EU referendum and given the links made by the fantastic journalism in The Observer and elsewhere with the Kremlin’s wider campaign of undermining and interfering in our and America’s politics, will the Secretary of State assure the House that all the inquiries and investigations that we have discussed here today get the full co-operation and support of the British intelligence and security services?

[Matt Hancock]

Yes.